Brooke Eby, ALS Patient and Advocate, to deliver Keynote Address at 2024 MDA Clinical & Scientific Conference
February 15, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, Feb. 15, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced Brooke Eby will be the keynote speaker at the 2024 MDA Clinical & Scientific...
Muscular Dystrophy Association Announces Seven Recipient Organizations of Advocacy Collaboration Grants
February 01, 2024 08:46 ET
|
Muscular Dystrophy Association
New York, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Today, the Muscular Dystrophy Association (MDA) announced $140,000 in funding from its MDA Advocacy Collaboration Grant Program, awarding the following...
Muscular Dystrophy Association Announces Recipient of 2024 MDA Legacy Award for Achievement in Research, is Jeffrey Chamberlain, Ph.D., Leading Professor in Gene Therapy
January 30, 2024 09:59 ET
|
Muscular Dystrophy Association
New York, Jan. 30, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today announced Jeffrey Chamberlain, Ph.D., a leading professor in gene therapy focused on Duchenne muscular...
Muscular Dystrophy Association Opens Registration for Campers and Volunteers for MDA Summer Camp 2024 to be Held at Locations Nationwide
January 22, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today the opening of registration for both campers and volunteers for its MDA Summer Camp program. MDA...
Muscular Dystrophy Association Announces 2024 National Ambassador Ira Walker
January 08, 2024 09:00 ET
|
Muscular Dystrophy Association
New York, Jan. 08, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) has selected 39-year-old Ira Walker from Fort Lauderdale, Florida, as its 2024 MDA National Ambassador. Walker...
Muscular Dystrophy Association Announces Acosta Group’s Historic $100 Million Fundraising Milestone
December 21, 2023 09:00 ET
|
Muscular Dystrophy Association
New York, Dec. 21, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) announced today that long-term partner Acosta Group has reached a historic $100 million milestone in fundraising...
Muscular Dystrophy Association Launches Holiday Retail Campaign in Thousands of Retail Locations Nationwide
November 01, 2023 09:00 ET
|
Muscular Dystrophy Association
New York, Nov. 01, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) today launched its largest Holiday Retail Campaign to fundraise in thousands of retail locations nationwide from...
Muscular Dystrophy Association Announces Collaboration with Mitsubishi Tanabe Pharma America for Remote Digital Technology Research Study for Amyotrophic Lateral Sclerosis (ALS)
October 30, 2023 09:01 ET
|
Muscular Dystrophy Association
New York, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Muscular Dystrophy Association (MDA) and Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced their collaboration for a remote observational...
Muscular Dystrophy Association-Supported Drug AGAMREE® (vamorolone) Approved for the Treatment of Duchenne Muscular Dystrophy by the FDA
October 26, 2023 16:24 ET
|
Muscular Dystrophy Association
New York, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of AGAMREE® (vamorolone), a structurally unique...
Muscular Dystrophy Association Celebrates FDA Approval of ZILBRYSQ® zilucoplan for the Treatment of Generalized Myasthenia Gravis (gMG) in Adult Patients
October 18, 2023 14:36 ET
|
Muscular Dystrophy Association
New York, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of ZILBRYSQ® zilucoplan for the treatment of...